Effectiveness and Safety of Upadacitinib in Combination with Topical Corticosteroids in Adolescent Patients with Moderate-to-Severe Atopic Dermatitis
Teppei Hagino,1 Risa Hamada,2 Mai Yoshida,2 Eita Fujimoto,3 Hidehisa Saeki,2 Naoko Kanda1 1Department of Dermatology, Nippon Medical School Chiba Hokusoh Hospital, Inzai, Japan; 2Department of Dermatology, Nippon Medical School, Tokyo, Japan; 3Fujimoto Dermatology Clinic, Funabashi, JapanCorresponde...
Main Authors: | Hagino T, Hamada R, Yoshida M, Fujimoto E, Saeki H, Kanda N |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2023-11-01
|
Series: | Clinical, Cosmetic and Investigational Dermatology |
Subjects: | |
Online Access: | https://www.dovepress.com/effectiveness-and-safety-of-upadacitinib-in-combination-with-topical-c-peer-reviewed-fulltext-article-CCID |
Similar Items
-
Predictive factors for responders to upadacitinib treatment in patients with atopic dermatitis
by: Teppei Hagino, et al.
Published: (2024-12-01) -
Effectiveness of switching from baricitinib 4 mg to upadacitinib 30 mg in patients with moderate-to-severe atopic dermatitis: a real-world clinical practice in Japan
by: Teppei Hagino, et al.
Published: (2023-12-01) -
Early itch relief with upadacitinib predicts later skin clearance in Atopic dermatitis
by: Teppei Hagino, et al.
Published: (2024-12-01) -
Upadacitinib for the treatment of concomitant psoriasis and atopic dermatitis: a case series
by: Luigi Gargiulo, et al.
Published: (2023-12-01) -
Observational 24‐week study to assess clinical response to upadacitinib posttrial in patients with moderate‐to‐severe atopic dermatitis
by: Ana Batalla, et al.
Published: (2023-09-01)